↑↓ navigate ↵ open esc close
SELL TO STATE.
Start free trial
Germany TED / Vergabe.de contract award · ocds-ted-281032-2024-1

Germany – Pharmaceutical products – Vertragsabschluss zum Arzneimittelwirkstoff Secukinumab, Verkaufsname: Cosentyx, Unt

AOK Rheinland/Hamburg - Die Gesundheitskasse awarded a contract of undisclosed value to Novartis Pharma GmbH for Healthcare & Medical in May 2024 — one of 117 awards this buyer has made.

Healthcare & Medical
13 May 2024
Award date
Not disclosed
Contract value

Buying agency

AOK Rheinland/Hamburg - Die Gesundheitskasse
117 Awards
€380K Avg award

Winning supplier

Novartis Pharma GmbH
6 Awards
3 Buyers
€3 Total won

Contract description

Germany – Pharmaceutical products – Vertragsabschluss zum Arzneimittelwirkstoff Secukinumab, Verkaufsname: Cosentyx, Unternehmen: Novartis Pharma GmbH

Premium

Related awards · AOK Rheinland/Hamburg - Die Gesundheitskasse

117 awards

The buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.

Tender no.SupplierAmountDateSector

Full dataset

Unlock the full data.

Subscribe to reveal every row, year-over-year trends, and CSV / API export.

Unlock full dataset →

73 more awards from this buyer · full history & CSV export

Premium

Other wins · Novartis Pharma GmbH

6 wins

The supplier's complete win history across every buyer it sells to — not just the handful shown here.

Tender no.BuyerAmountDateSector
Locked rows — unlock the full dataset below.

Premium · full dataset

See the full award context.

Competing bids, award margins and every related contract for AOK Rheinland/Hamburg - Die Gesundheitskasse and Novartis Pharma GmbH — one subscription unlocks everything.

Sign Up Free →

Free account · cancel anytime · 14-day money-back

Sign Up